Redistribution of CD163+ CCR2+ Monocytes from Blood Circulation to the Ascites as a Potential Indicator of Progression in High-Grade Serous Ovarian Cancer
This study aimed to identify tumor-specific changes in circulating and ascites-derived monocytes from high-grade serous ovarian carcinoma (HGSOC) patients using flow cytometry, immunohistochemistry, RNA sequencing, and in vitro experiments. Our results demonstrate that the tumor induces a decrease in the total number of circulating monocytes but an increase in the proportion of CD163+ monocytes. Notably, CD206-expressing monocytes were reduced in HGSOC patients, with extremely low CD206 levels in peripheral blood mirroring those in tumor tissues. In contrast, a marked accumulation of CD206-positive monocyte-derived macrophages was observed in malignant ascites. The presence of CCR2 on the monocyte surface further amplified the increase in CD163+ monocytes and reversed the decrease in CD206+ monocytes in cancer patients. Transcriptional levels of CD163 corresponded to protein levels and were elevated in monocytes of HGSOC patients. Moreover, the percentage of CD163+CCR2+ monocytes was decreased in peripheral blood but increased in ascites of patients with progressive disease. A functional migration assay confirmed extensive recruitment of monocytes toward malignant ascites in vitro. Collectively, our findings suggest that the redistribution of CD163+CCR2+ monocytes from blood to malignant ascites may represent a candidate indicator of disease progression in HGSOC patients.
Authors
- Julia G. Kzhyshkowska (ORCID: https://orcid.org/0000-0003-0898-3075)
- Anna Valerievna Kalinchuk (ORCID: https://orcid.org/0000-0003-2106-3513)
- Tatiana Sudarskikh (ORCID: https://orcid.org/0009-0001-3835-5259)
- Irina Larionova (ORCID: https://orcid.org/0000-0001-5758-7330)
- Pavel S. Iamshchikov (ORCID: https://orcid.org/0000-0002-0646-6093)
- Л. А. Коломиец (ORCID: https://orcid.org/0000-0002-6854-8940)
- Shuo Chen (ORCID: https://orcid.org/0000-0002-5122-3656)
- Evgeniya S. Grigoryeva (ORCID: https://orcid.org/0000-0003-4671-6306)
- Kseniia Shalygina (ORCID: https://orcid.org/0009-0000-6159-5173)
- Анна Казакова (ORCID: https://orcid.org/0000-0003-0194-6677)
- Yang Zhao
- Svetlana Iamshchikova
- Alexandr Yatskovskyi
- Alisa Villert
Institutions
- Russian Academy of Sciences (RU)
- National Research Tomsk State University (RU)
- Heidelberg University (DE)
- Third Affiliated Hospital of Guangzhou Medical University (CN)
- Tomsk National Research Medical Center (RU)
- Tomsk Cancer Research Institute (RU)
- Liaoning Cancer Hospital & Institute (CN)
- Medizinische Fakultät Mannheim (DE)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- International Journal of Molecular Sciences
- Published
- 2026-11-19
- DOI
- https://doi.org/10.3390/ijms272210437
- Primary Topic
- Immune cells in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00